A clinical trial enrolled 10 adults to treat paralysis from traumatic spinal cord injury, NewsMedical reports.
After stem cell injection, the first patient demonstrated improvement in motor and sensory functions, and had no significant adverse effects, according to a case report published in Mayo Clinic Proceedings.
Here is the original report: Bydon, M., et al. (2019) CELLTOP Clinical Trial: First Report From a Phase 1 Trial of Autologous Adipose Tissue–Derived Mesenchymal Stem Cells in the Treatment of Paralysis Due to Traumatic Spinal Cord Injury. Mayo Clinic Proceedings.